Jeffrey Sundram
@Cowen And Company, Llc
Latest period2024 - Q3ReportedManaged Assets$2.969TTotal holdings564
Assets growth rate-18.35%Assets growth rate (2-Q avg)11.26%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Cowen And Company, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 564 positions.
Assets under management
The assets under management (AUM) of Cowen And Company, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.969T in assets, with a quarterly growth rate of -18.35% and a 2-quarter average growth rate of 11.26%. The portfolio is managed by Jeffrey Sundram, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
IMAQInternational Media Acquisit
| 0% | $588.075M 51,137 shares@ $11500.0 avg price | Exited |
BLUAFBlueriver Acquisition Corp
| 0% | $553M 50,000 shares@ $11060.0 avg price | Exited |
SRPTSarepta Therapeutics Inc
| 0% | $467.005M↑ Call 24,500 shares@ $19061.43 avg price | Exited |
ITTItt Inc
| 0% | $440.98M 23,255 shares@ $18962.81 avg price | Exited |
DISTDistoken Acquisition Corp
| 0% | $431.2M 40,000 shares@ $10780.0 avg price | Exited |
GAQGeneration Asia I Acquisitio
| 0% | $403.121M 35,833 shares@ $11250.0 avg price | Exited |
ELVElevance Health Inc
| 0% | $371.974M 6,210 shares@ $59899.2 avg price | Exited |
FIACWFocus Impact Acquisition Cor
| 0% | $357.62M 32,088 shares@ $11144.98 avg price | Exited |
CERECerevel Therapeutics Hldng I
| 0% | $287.499M↓ Put 200,000 shares@ $1437.5 avg price | Exited |
MIRMirion Technologies Inc
| 0% | $268.5M 25,000 shares@ $10740.0 avg price | Exited |